BOSTON SCIENTIFIC CORPORATION Payments for (Proceeds from) Hedge, Investing Activities
BOSTON SCIENTIFIC CORPORATION (BSX) reported Payments for (Proceeds from) Hedge, Investing Activities of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-18.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromHedgeInvestingActivities · last filed 2025-02-18
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2024-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2023-12-31 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for the quarter ending 2023-09-30 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2024 was $0.00.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2023 was -$2.00M.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2022 was -$56.00M.
- BOSTON SCIENTIFIC CORPORATION payments for (proceeds from) hedge, investing activities for fiscal 2021 was -$15.00M.
| Period end | Payments for (Proceeds from) Hedge, Investing Activities 3 month | Payments for (Proceeds from) Hedge, Investing Activities 6 month | Payments for (Proceeds from) Hedge, Investing Activities 9 month | Payments for (Proceeds from) Hedge, Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $0.00 10-Q · filed 2024-11-01 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | -$2.00M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | -$2.00M 10-Q · filed 2024-11-01 | ||
| 2023-06-30 | -$2.00M 10-Q · filed 2024-08-01 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | -$56.00M 10-K · filed 2025-02-18 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$56.00M 10-Q · filed 2023-11-01 | ||
| 2022-06-30 | -$56.00M 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | -$15.00M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 | |||
| 2019-12-31 | $199.00M 10-K · filed 2022-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |